Implementation Research - The Aurum Institute

It's time to End TB

In recognition of World TB Day and for the rest of TB Month, Aurum is highlighting some of its staff working to End TB. ...
Progress on TB care should not reversed by COVID-19

“The progress made in TB prevention and care should not reversed by the COVID-19 pandemic,” says Professor Geoffrey Setswe, Aurum's Managing Director: Implementation Research Division. Speaking a...
Smart Medication Container Included in GDF product Catalog

Stop TB Partnership’s Global Drug Facility (GDF) and the Unitaid-funded Adherence Support Coalition to End TB (ASCENT project) announce the inclusion of the first digital adherence technology (DAT) ...
South Africans should mobilise to support the NHI

This article was published in The Conversation on 13 January 2020. Lengthy negotiations ended in good news recently when the price of rifapentine, a lifesaving antibiotic, was marked down by 66% by i...
Join a live webinar and discussion with Prof Salome Charalambous on "Differentiated Service Delivery for TB Preventive Therapy

Tuberculosis (TB) remains a tremendous global public health challenge. TB Preventive Therapy (TPT) has demonstrated ~60-70% efficacy for reducing TB incidence. At the high level UN meeting of 40 coun...
World TB Day- TB treatments are notoriously hard to stick to: shorter regimens offer a breakthrough

This article by Prof Violet Chihota, was originally published in The Conversation Tuberculosis (TB) is a major cause of illness and death around the world. In 2019, 10 million people fell ill with...
Aurum conducts COVID-19 contact tracing

After a medical doctor at an academic hospital in Gauteng tested positive for COVID-19, a team of Aurum staff were deployed to trace more than 300 patients who were possible contacts of the clinician....
After setbacks, rollout of new TB prevention pills to start in six districts

This article was originally written by Tiyese Jeranji for Spotlight on 14th April 2021. After various delays and setbacks, new, less toxic, short-course tuberculosis (TB) prevention therapy is fi...
FIND and Unitaid invest US$ 50 million to speed lifesaving testing and treatment solutions to the COVID-19 pandemic’s frontlines

Geneva, 9 November 2021 – FIND, Unitaid, and partners are joining forces to quickly deliver new end-to-end strategies that will accelerate and enhance improved access to diagnostics and treatment, ...
Aurum Annual Report 2021

Aurum Board Chairperson Ms Phangisile Mtshali characterises 2021 as a year of adapting and building resilience. She writes in the Aurum Annual Report 2021, that the organisation had to pivot and seiz...
Celebrating women in science this IWD

In recognition of International Women’s Day, Aurum celebrates some of its leading UNESCO data states, less than 30% of the world’s researchers are women. Not a single country can claim to have...
Call to action for an invigorated drive to scale up TB prevention

...
Press Statement: Global Consortium welcomes reduced price for patient-friendly treatment to prevent tuberculosis

The Aurum Institute and its partners also announce the launch of the next phase of work to improve access to shorter TB prevention treatments for children and pregnant women Johannesburg, 3 Aug...
Aurum showcases expertise at SA TB Conference

SA TB Conference delegates packed the hall for an Aurum satellite session on: Scaling up shorter TB preventive treatment (TPT) - is there a role for new TB infection tests in South Africa? Prof Viol...
KAB study finds high COVID-19 awareness

As South Africa experiences a surge in the number of COVID-19 cases, the Aurum Institute has released findings of a research study on the knowledge, attitudes and behaviors which could be driving the ...
Aurum at the 53rd Union World Conference on Lung Health

The Aurum Institute will join colleagues, partners, advocates and friends at the biggest scientific conference on lung health, The Union World Conference on Lung Health which will take place virtually...
250,000 patients to benefit from free access to short-course TB prevention treatment across seven countries

Johannesburg, 24 March 2023 – The Unitaid-funded IMPAACT4TB Consortium, led by the Aurum Institute, announced today that it will provide 250,000 patient courses of short course rifapentine-based pre...
Part One: Reflections from the 11th SA AIDS Conference

This is the first part of a three-part series showcasing the important thoughts shared by Aurum delegates at the 11th SA AIDS Conference in Durban. The conference brought together a diverse group of...
Aurum staff appointed to Vanderbilt University

The Aurum Institute is proud to announce that 10 senior staff members have been appointed in various adjunct positions at the Department of Medicine in the Vanderbilt University School of Medicine. T...
World Aids Day 2020: Gains against HIV should not be derailed by COVID-19

Let us not lose sight of HIV in the face of COVID-19. This was the World AIDS Day message from Professor Dave Clark, Group Chief Operating Officer and Chief Executive Officer: Southern Africa at the...